TLDR
- AXON fell 8.21%, hitting a 52-week low of $396.41 — down 55% from its 52-week high of $885.91
- A court hearing over lawsuits challenging Axon’s $1.3 billion Scottsdale HQ project is weighing on sentiment
- BofA and RBC Capital both cut their price targets, to $700 and $735 respectively
- The stock is down 27.27% year-to-date and 42% over the past six months
- InvestingPro flags the stock as overvalued based on Fair Value calculations
Axon Enterprise had a rough Monday. The stock sank more than 8% and touched its lowest point in a year, as a combination of legal uncertainty, analyst caution, and a wider selloff in growth tech all hit at once.
The 52-week low of $396.41 puts AXON a staggering 55% below its high of $885.91, reached within the past year. Over the past six months alone, the stock has fallen around 42%.
Traders are keeping a close eye on an upcoming court hearing tied to lawsuits challenging the legality of Axon’s planned $1.3 billion headquarters development in Scottsdale, Arizona. The outcome could carry real consequences for the company’s long-term capital plans.
That legal overhang is landing at a difficult time. Richly valued SaaS and growth-tech names have been under broad pressure, and investors have been rotating away from the sector. Axon, which trades at a premium valuation, has not been spared.
Wall Street Trims Targets
BofA Securities lowered its price target on AXON to $700, pointing to the broader software sector selloff as a key concern. RBC Capital also cut its target, moving it down to $735, citing Axon’s fiscal 2025 results and 2026 guidance as a reference point for where the stock should be priced.
Craig-Hallum trimmed its target to $820, flagging valuation concerns despite acknowledging Axon’s strong Q4 results and better-than-expected fiscal 2026 guidance.
Not everyone is bearish. TD Cowen went the other way, raising its price target to $950 after pointing to Q4 bookings growth of 53% and fiscal 2026 revenue guidance that came in ahead of expectations.
Oppenheimer maintained an Outperform rating on AppLovin, noting that its AXON advertising platform — a separate product, unrelated to Axon Enterprise — is still gaining ground with mid-market advertisers.
Fundamentals Still Intact, But Sentiment Has Shifted
Axon’s underlying business has shown real momentum. The 53% bookings growth in Q4 and a fiscal 2026 revenue outlook that beat analyst forecasts are not the numbers of a company in operational trouble.
But the market is in a show-me mood right now, and premium valuations are being tested hard. InvestingPro currently flags AXON as overvalued based on Fair Value metrics, which isn’t helping the bull case in a risk-off tape.
Average daily trading volume sits around 992,161, and the technical sentiment signal is currently a Hold.
Year-to-date, AXON is down 27.27%, making it one of the harder-hit names in the public-safety and AI-tech space.
The next key moment to watch is the court hearing on the Scottsdale headquarters lawsuits, which could add another layer of uncertainty for investors already navigating a choppy market.
Considering a new stock? You may want to see what’s on our watchlist first.
Our team at Knockout Stocks follows top-performing analysts and market-moving trends to spot potential winners early. We’ve identified five stocks gaining quiet attention that could be worth watching now. Create your free account to unlock the full report and get ongoing stock insights.Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
